Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02142283 · ClinicalTrials.gov registry record · NA
Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo
A NA study, sponsored by Stryker Neurovascular.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT02142283 is a NA study that has completed, run by Stryker Neurovascular. The registered enrollment target is 206 participants.
The verdict
NCT02142283, a NA study, has completed, sponsored by Stryker Neurovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the hypothesis that Trevo thrombectomy plus medical management leads to superior clinical outcomes at 90 days as compared to medical management alone in appropriately selected subjects experiencing an acute ischemic stroke when treatment is initiated within 6-24 hours after last seen well.
Interventions
- OTHER Medical Management
- DEVICE Trevo Thrombectomy Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02142283
The ClinicalTrials.gov registry entry for NCT02142283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Neurovascular, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medical Management is the first listed.
NCT02142283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02142283 about?
NCT02142283 is a clinical study titled "Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo". The purpose of the study is to evaluate the hypothesis that Trevo thrombectomy plus medical management leads to superior clinical outcomes at 90 days as compared to medical management alone in appropriately selected subjects experiencing an acute ischemic stroke when treatment is initiated within 6-...
What is the current status of trial NCT02142283?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2014-07. Estimated completion is 2017-05-15.
What interventions are being tested in trial NCT02142283?
The interventions under investigation include: Medical Management (OTHER), Trevo Thrombectomy Procedure (DEVICE).
Who is sponsoring clinical trial NCT02142283?
This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.